BlackRock Portfolio Management LLC 13D and 13G filings for Vanda Pharmaceuticals Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-04-29 4:08 pm Sale | 2026-03-31 | 13G | VANDA PHARMACEUTICALS INC VNDA | BlackRock Portfolio Management LLC | 2,508,488 4.200% | -743,075 (-22.85%) | Filing |
| 2026-01-21 12:26 pm Sale | 2025-12-31 | 13G | VANDA PHARMACEUTICALS INC VNDA | BlackRock Portfolio Management LLC | 3,251,563 5.500% | -1,227,523 (-27.41%) | Filing |
| 2025-04-15 5:04 pm Purchase | 2025-03-31 | 13G | VANDA PHARMACEUTICALS INC VNDA | BlackRock Portfolio Management LLC | 4,479,086 7.700% | 4,479,086 (New Position) | Filing |